These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2179957)

  • 21. Chemical carcinogenesis: the liver as a model.
    Farber E; Sarma DS
    Pathol Immunopathol Res; 1986; 5(1):1-28. PubMed ID: 3022277
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of the tumor promoter 2-acetylaminofluorene and of 4-acetylaminofluorene on rat liver growth.
    Gerlyng P; Seglen PO
    Bull Cancer; 1990; 77(5):461-6. PubMed ID: 2400817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 24. Stochastic description of initiation and promotion in experimental carcinogenesis.
    Luebeck EG; Moolgavkar SH
    Ann Ist Super Sanita; 1991; 27(4):575-80. PubMed ID: 1840318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
    Ito N; Tatematsu M; Nakanishi K; Tsuda H
    Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of 2 different carcinogens used separately and in combination on the liver carcinogenesis in rodents].
    Wojnar A
    Patol Pol; 1980; 31(3):405-15. PubMed ID: 6784094
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
    Popp JA; Cattley RC; Miller RT; Marsman DS
    Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell proliferation in N-nitrosodiethylamine (DEN)-treated rat liver parenchyma correlated with tumor development.
    Miyazaki T; Yamashita Y; Takahashi M; Tsuruta J; Ishimaru Y
    Hepatogastroenterology; 1996; 43(9):756-63. PubMed ID: 8799426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis).
    Grasl-Kraupp B; Luebeck G; Wagner A; Löw-Baselli A; de Gunst M; Waldhör T; Moolgavkar S; Schulte-Hermann R
    Carcinogenesis; 2000 Jul; 21(7):1411-21. PubMed ID: 10874021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of hepatocarcinogenesis after single exposure of synchronized cells of the regenerating liver to N-nitrosodiethylamine and subsequent administration of phenobarbital].
    Osipova LA; Vinarchuk MP; Khranovskaia LN; Bykorez AI
    Eksp Onkol; 1987; 9(5):61-4. PubMed ID: 3691396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental models of 2-stage carcinogenesis].
    Turusov VS
    Eksp Onkol; 1985; 7(3):5-12. PubMed ID: 3893973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
    Pitot HC; Goldsworthy T; Moran S
    J Supramol Struct Cell Biochem; 1981; 17(2):133-46. PubMed ID: 7033553
    [No Abstract]   [Full Text] [Related]  

  • 35. Co-carcinogenesis.
    Clayson DB
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():35-51. PubMed ID: 6385621
    [No Abstract]   [Full Text] [Related]  

  • 36. Promotion of aflatoxin B1-induced hepatocarcinogenesis by dichlorodiphenyl trichloroethane (DDT).
    Angsubhakorn S; Pradermwong A; Phanwichien K; Nguansangiam S
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):613-23. PubMed ID: 12693600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-to-cell communication: relationship of stem cells to the carcinogenic process.
    Trosko JE; Chang CC; Madhukar BV
    Prog Clin Biol Res; 1990; 331():259-76. PubMed ID: 2179959
    [No Abstract]   [Full Text] [Related]  

  • 38. Gap junctional intercellular communication in hepatic carcinogenesis.
    Klaunig JE; Hartnett JA; Ruch RJ; Weghorst CM; Hampton JA; Schafer LD
    Prog Clin Biol Res; 1990; 340D():165-74. PubMed ID: 2371293
    [No Abstract]   [Full Text] [Related]  

  • 39. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation.
    Jirtle RL; Meyer SA; Brockenbrough JS
    Prog Clin Biol Res; 1991; 369():209-16. PubMed ID: 1946518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.